| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |